IP Library › Assignment 064894/0379
Patent Assignment
Reel/Frame 064894/0379

Assignment of Assignor's Interest

Recorded: 2023-09-13 Pages: 6
Assignor
TABUTEAU, HERRIOT
Executed: 2023-09-11
Assignee
AXSOME THERAPEUTICS, INC.
ONE WORLD TRADE CENTER, 22ND FLOOR, NEW YORK, NEW YORK, 10007
Covered Properties (10)
Pharmaceutical Compositions Comprising Meloxicam
Pharmaceutical Compositions Comprising Bupropion and Cysteine
Microparticles Containing Bupropion
Pharmaceutical Compositions Comprising Meloxicam
Application: 18/323,040 →
Publication: US 2023/0372355
Pharmaceutical Compositions Comprising Meloxicam
Application: 18/337,552 →
Publication: US 2023/0338390
Pharmaceutical Compositions Comprising Meloxicam
Application: 18/347,970 →
Publication: US 2023/0355637
Pharmaceutical Compositions Comprising Meloxicam
Application: 18/366,992 →
Publication: US 2024/0197887
Dosage Forms and Methods for Enantiomerically Enriched or Pure Bupropion
Application: 18/461,389 →
Publication: US 2023/0414538
Solriamfetol for Treating Adults with Adhd
Application: 63/508,847 →
Pharmaceutical Compositions Comprising Meloxicam
Application: 63/579,833 →
Related Assignments (3)
Other recorded transfers of the patents in this record — the chain of ownership.
Assignment of Assignor's Interest Jun 23, 2023
From: TABUTEAU, HERRIOT
To: AXSOME THERAPEUTICS, INC.
Reel/Frame 064042/0879 →
Security Interest May 9, 2025
From: AXSOME THERAPEUTICS, INC.; AXSOME MALTA LTD.
To: WILMINGTON TRUST, NATIONAL ASSOCIATION
Reel/Frame 071247/0836 →
Assignment of Assignor's Interest Mar 4, 2026
From: AXSOME THERAPEUTICS, INC.
To: ANTECIP BIOVENTURES II LLC
Reel/Frame 073973/0726 →